###begin article-title 0
###xml 0 9 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
TNF-alpha -308 G>A and -238 G>A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 248 257 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 264 274 256 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945; </italic>
###xml 290 300 278 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945; </italic>
TNF-alpha has been suggested to participate in the pathogenesis of exfoliation glaucoma (XFG). The purpose of the present study was to investigate a hypothesized association between two common functional polymorphisms in the promoter region of the TNF-alpha gene (TNF-alpha -308 G>A, , and TNF-alpha -238 G>A, ) and the presence of XFG in a Caucasian population.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 172 181 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 195 204 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 45 57 <span type="species:ncbi:9606">participants</span>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
The present case-control study comprised 408 participants (204 patients with XFG and 204 control subjects). Control subjects were matched for age and sex. Genotypes of the TNF-alpha -308 G>A and TNF-alpha -238 G>A polymorphisms were determined by polymerase chain reaction (restriction fragment length polymorphism).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 162 171 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 318 327 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
No significant differences regarding genotype distribution or allelic frequencies were found between patients and control subjects (p>0.025). The presence of the TNF-alpha -308 G-allele was associated with an insignificant odds ratio of 0.98 (95% confidence interval [CI]: 0.66-1.46; p=0.99) while the presence of the TNF-alpha -238 G-allele was associated with an insignificant odds ratio of 0.64 (95% CI: 0.33-1.23; p=0.25).
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 31 40 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 58 67 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
Our data suggest that both the TNF-alpha -308 G>A and the TNF-alpha -238 G>A polymorphisms are unlikely to be major risk factors for XFG in an European population of Caucasian descent.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 833 838 833 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 931 932 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1098 1100 1098 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
Exfoliation syndrome (XFS; OMIM ) is recognized as a general elastic fibrillopathy, leading to accumulation of characteristic abnormal fibrillar material in different intra- and extraocular tissues, e.g., trabecular meshwork, iris stroma, conjunctiva, kidney, lung, and heart [1,2]. Glaucomatous optic neuropathy due to XFS (exfoliation glaucoma, XFG) is caused by deposition of exfoliation material and liberated iris pigment in the trabecular meshwork leading to elevation of intraocular pressure [3]. Results from family-based studies and from a study investigating the loss of heterozygosity in specimens of the anterior segment in individuals with XFS indicate a high grade of heritability of XFS [4-8]. Recently, two common non-synonymous single nucleotide polymorphisms (SNPs;  and ) in the lysyl oxidase-like protein 1 gene (LOXL1; OMIM ) that confer increased risk for the development of XFS and XFG have been identified [9]. However, as the prevalences of these polymorphisms are also high in individuals without XFS, other, as yet unkown genetic or enviromental factors may be involved [10-16].
###end p 11
###begin p 12
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 598 605 <span type="species:ncbi:9606">patient</span>
The degradation of the extracellular matrix (ECM) depends on the activity of a group of highly regulated endopeptidases named matrix metalloproteinases (MMPs), which are grouped in four families consisting of 23 members in total, each with a specific spectrum of ligands [17]. Uncontrolled activation of MMPs is counterbalanced by specific tissue inhibitors of metalloproteinases (TIMPs), and a delicate balance of MMPs and TIMPs is required for physiologic ECM turnover. Interestingly, increased levels of TIMP-1 and TIMP-2 and decreased levels of MMP-2 have been detected in the aqueous humor of patient with XFS [18,19]. An impaired balance between MMPs and TIMPs may thus contribute to the development of XFS.
###end p 12
###begin p 13
###xml 203 205 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 350 352 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 353 355 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
Tumor necrosis factor-alpha (TNF-alpha, OMIM ) is a ubiquitous cytokine involved in various physiologic as well as pathologic processes like inflammation, immunoregulation, proliferation, and apoptosis [20]. Notably, several in vitro studies provided evidence that TNF-alpha is also capable of inducing both increased synthesis and activity of MMPs [21-24].
###end p 13
###begin p 14
###xml 62 71 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 164 173 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 263 272 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 413 415 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 416 418 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 504 506 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 507 509 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
Two common functional polymorphisms in the promoter region of TNF-alpha have been identified. The first is characterized by a G to A substitution at position -308 (TNF-alpha -308 G>A, ) while the second is characterized by a G to A substitution at position -238 (TNF-alpha -238 G>A, ). In vitro studies of these polymorphisms have been shown to increase TNF-alpha production after lipopolysaccharide stimulation [25-27]. Other studies, however, were unable to confirm this effect on TNF-alpha synthesis [27-29].
###end p 14
###begin p 15
###xml 37 39 37 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 78 87 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 273 282 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 370 379 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 393 402 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
Only recently, Tekeli and coworkers [30] found an increased prevalence of the TNF-alpha -308 GG genotype among 110 Turkish patients with XFG. This finding, however, has not yet been confirmed in other populations, which is mandatory to draw firm conclusions on the role of TNF-alpha polymorphisms. Our study was set to investigate a hypothesized association between the TNF-alpha -308 G>A and TNF-alpha -238 G>A polymorphisms and the presence of XFG.
###end p 15
###begin title 16
Methods
###end title 16
###begin p 17
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 147 159 <span type="species:ncbi:9606">participants</span>
###xml 241 253 <span type="species:ncbi:9606">Participants</span>
Two hundred and four unrelated patients with XFG and 204 control subjects were enrolled in the present retrospective case-control study. All study participants were Caucasians from the same geographical area in the southern part of Austria. Participants were seen at the Department of Ophthalmology, Medical University Graz (Graz, Austria) between May 2003 and September 2008 and gave informed written consent before enrollment. The study was conducted in accordance with the National Gene Technology Act of Austria and the guidelines of the local ethics committee.
###end p 17
###begin p 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 491 503 <span type="species:ncbi:9606">participants</span>
Patients with XFG underwent slit lamp biomicroscopy in mydriasis, testing for best corrected visual acuity, Goldmann applanation tonometry, gonioscopy, pachymetry, and standard automated perimetry (Octopus 101, program G2; Interzeag, Schlieren, Switzerland) or in cases of profoundly decreased visual acuity, Goldmann perimetry. Control subjects underwent slit lamp biomicroscopy in mydriasis, Goldmann applanation tonometry, and testing for best corrected visual acuity. Optic discs in all participants were assessed by glaucoma specialists (C.F., G.M.).
###end p 18
###begin p 19
XFG was defined by the presence of typical exfoliation material on the anterior lens capsule, an intraocular pressure before initiation of a pressure lowering therapy of at least 22 mmHg, an open anterior chamber angle, optic disc changes characteristic for glaucoma (notching, thinning of the neuroretinal rim, increased cup/disc ratio in relation to the optic disc size), visual field defects characteristic for glaucoma (inferior or superior arcuate scotoma, nasal step, paracentral scotoma), and absence of conditions leading to secondary glaucoma.
###end p 19
###begin p 20
Control subjects showed biomicroscopically no evidence of exfoliation material on the anterior capsule of the lens and no morphological damage indicative for open-angle or angle closure glaucoma. Control subjects were admitted to our department for cataract surgery.
###end p 20
###begin title 21
Genotype determination
###end title 21
###begin p 22
###xml 239 241 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 641 642 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Venous blood was collected in 5 ml EDTA tubes. DNA was isolated using QIAamp DNA blood mini-kit (QIAGEN, Venlo, Netherlands) and stored at -20 degreesC. All polymerase chain reactions (PCRs) were run under conditions previously described [31]. Primer sequences for the gene polymorphism at -308 were forward 5'-GGG ACA CAC AAG CAT CAA GG-3' and reverse 5'-GGG ACA CAC AAG CAT CAA GG-3', for the polymorphism at -238 forward 5'-ATC TGG AGG AAG CGG TAG TG-3' and reverse 5'-AGA AGA CCC CCC TCG GAA CC-3'. DNA samples were amplified in 25 microl aliquots containing 200 microM deoxynucleoside triphosphate, 10 microM of each primer, 1.5 mM MgCl2, 1 microl DNA sample, and 2 U Taq polymerase (Applied Biosystems, Foster City, CA). Annealing temperature was 62 degreesC. The PCR products were digested at 37 degreesC with NcoI to detect the SNP in the -308 gene allele and MspI to detect the polymorphism of the -238 nucleotide. The PCR product was then subjected to 3% agarose-gel electrophoresis. "No target" controls were included in each PCR batch to ensure that reagents had not been contaminated.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 253 254 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Descriptive statistics were used to calculate frequencies and percentages of discrete variables. Continuous data are given as mean+/-standard deviation (SD). Means were compared using the Mann-Whitney test. Proportions of groups were compared by the chi2 test. The odds ratio (OR) and 95% confidence interval (95% CI) were calculated by logistic regression. According to the Bonferroni correction, the criterion for statistical significance was set at p</=0.025. Hardy-Weinberg equilibrium has been calculated using HW Diagnostics-Version 1.beta (Fox Chase Cancer Center, Philadelphia, PA). Statistical analysis was done using the SPSS statistical package (version 14.0; SPSS, Chicago, IL).
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 35 43 <span type="species:ncbi:9606">patients</span>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
The present study comprised of 204 patients with XFG (118 female and 86 male) and 204 control subjects, all matched for age and gender. The mean age of patients with XFG was 76.1+/-7.0 years (range: 60.6-91.7 years), and the mean age for control subjects was 75.3+/-6.9 years (range: 60.3-93.1 years).
###end p 26
###begin p 27
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 255 264 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 278 287 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 443 452 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 470 479 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 582 591 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 808 817 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 923 932 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 985 994 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
###xml 522 530 <span type="species:ncbi:9606">patients</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
The observed genotype distributions did not deviate from those predicted by the Hardy-Weinberg equilibrium, and for control subjects, they were similar to those reported for Caucasian populations [32]. Table 1 shows the genotype and allele frequencies of TNF-alpha -308 G>A and TNF-alpha -238 G>A polymorphisms in patients with XFG and control subjects. No significant differences in either genotype distribution or allelic frequencies of the TNF-alpha -308 G>A and the TNF-alpha -238 G>A polymorphisms were found between patients with XFG and control subjects. The presence of the TNF-alpha -308 G-allele was associated with an insignificant odds ratio of 0.98 (95% CI: 0.66-1.46; p=0.99) for XFG. An insignificant odds ratio of 0.64 (95% CI: 0.33-1.23; p=0.25) for XFG was also found among carriers of the TNF-alpha -238 G-allele. The present study had a statistical power of 0.80 to detect an odds ratio >/=2.09 for the TNF-alpha -308 G/G genotype and an odds ratio >/=4.19 for the TNF-alpha -238 G/G genotype in patients with XFG.
###end p 27
###begin title 28
Distribution of genotypes and allelic frequencies.
###end title 28
###begin p 29
###xml 16 25 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 39 48 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Distribution of TNF-alpha -308 G>A and TNF-alpha -238 G>A genotypes and allelic frequencies in patients with exfoliation glaucoma and control subjects in an European population of Caucasian descent. Numbers for genotypes are n (%).
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 370 372 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 373 375 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 527 529 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 576 581 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP-3</italic>
###xml 583 588 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP-9</italic>
###xml 590 596 578 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIMP-1</italic>
###xml 602 608 590 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIMP-3</italic>
###xml 640 642 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 169 172 <span type="species:ncbi:10116">rat</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
###xml 535 540 <span type="species:ncbi:10090">mouse</span>
TNF-alpha has been shown to affect activity and synthesis of MMPs and TIMPs, which play a major role in the turnover of the ECM in the trabecular meshwork. Treatment of rat cardiac fibroblasts with TNF-alpha exhibited an increased activity of MMP-2, MMP-9, and MMP-13, while stimulation of human smooth muscle cells led to increased activity of MMP-1, MMP-3, and MMP-9 [21,24]. Furthermore, in an in vitro study using human endothelial cells, TNF-alpha induced increased levels of MMP-14, which in turn activated latent MMP-2 [22]. In mouse osteoblastic cells, mRNA levels of MMP-3, MMP-9, TIMP-1, and TIMP-3 were upregulated by TNF-alpha [23].
###end p 31
###begin p 32
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 628 637 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 845 854 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1032 1041 1024 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1088 1097 1076 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1191 1200 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1226 1235 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
###xml 535 543 <span type="species:ncbi:9606">patients</span>
###xml 760 768 <span type="species:ncbi:9606">patients</span>
###xml 791 799 <span type="species:ncbi:9606">patients</span>
Various studies provided evidence that MMPs and TIMPs may be involved in the pathogenesis of XFG. Schlotzer-Schrehardt and coworkers found a decreased ratio of MMP-2 to TIMP-2 in the aqueous humor of patients with XFG, which has been corroborated by Maatta and coworkers [18,19]. Ho and coworkers [33] reported significantly increased levels of TIMP-1 in the aqueous humor of patients with XFS, while in an immunohistochemical study Ronkko and coworkers [34] found decreased ratios of MMPs to TIMPs in trabecular meshwork specimens of patients with XFG. Remarkably, Tekeli and coworkers [30] investigating the common functional TNF-alpha -308 G>A polymorphism suggested that this polymorphism may exert protection against XFG. In their study that included 110 patients with XFG, 6.4% of the patients with XFG were found to have the heterozygote TNF-alpha -308 GA genotype compared to 16.4% of the control subjects. In the present study, no significant differences were found in the genotype distribution or allelic frequency of the TNF-alpha -308 G>A polymorphism as was the case for the TNF-alpha -238 G>A polymorphism. An insignificant odds ratio for XFG was found in both carriers of the TNF-alpha -308 G-allele and of the TNF-alpha -238 G-allele, suggesting that these polymorphisms themselves are not major risk factors for XFG. Possible explanations for these conflicting results may include small sample size as well as varying genotype distributions among different populations.
###end p 32
###begin p 33
A limitation of the present study is the sample size, whereby minor genetic effects may be undetected. Furthermore, it can not be ruled out that other, as yet unknown functional polymorphisms in the TNF-alpha gene influence susceptibility to XFG.
###end p 33
###begin p 34
###xml 4 13 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 153 162 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 321 323 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 324 326 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
The TNF-alpha -308 G>A polymorphism has also been recently implicated in the pathogenesis of primary open-angle glaucoma. An increased prevalence of the TNF-alpha -308 A-allele was reported in patients with primary open-angle glaucoma in a Chinese study, albeit this result could not be replicated in subsequent studies [35-37].
###end p 34
###begin p 35
###xml 70 79 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 97 106 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
In conclusion, based on the results of the present study, neither the TNF-alpha -308 G>A nor the TNF-alpha -238 G>A polymorphism is a major risk factor among Caucasian patients with XFG.
###end p 35
###begin title 36
Acknowledgments
###end title 36
###begin p 37
The authors thank Ms. Elschatti, Ms. Fischl, Ms. Trummer, and Ms. Wachswender for their skillful technical assistance.
###end p 37
###begin title 38
References
###end title 38
###begin article-title 39
Exfoliation syndrome.
###end article-title 39
###begin article-title 40
Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?
###end article-title 40
###begin article-title 41
Why is glaucoma associated with exfoliation syndrome?
###end article-title 41
###begin article-title 42
Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation.
###end article-title 42
###begin article-title 43
Exfoliation syndrome: clinical and genetic features.
###end article-title 43
###begin article-title 44
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Early diagnosis of exfoliation syndrome in the offspring of affected patients.
###end article-title 44
###begin article-title 45
Pseudoexfoliation syndrome in Icelandic families.
###end article-title 45
###begin article-title 46
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Loss of heterozygosity in patients with pseudoexfoliation syndrome.
###end article-title 46
###begin article-title 47
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
###end article-title 47
###begin article-title 48
###xml 60 68 <span type="species:ncbi:9606">patients</span>
LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.
###end article-title 48
###begin article-title 49
Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort.
###end article-title 49
###begin article-title 50
DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity.
###end article-title 50
###begin article-title 51
###xml 138 144 <span type="species:ncbi:9606">people</span>
Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.
###end article-title 51
###begin article-title 52
Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.
###end article-title 52
###begin article-title 53
Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India.
###end article-title 53
###begin article-title 54
Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.
###end article-title 54
###begin article-title 55
Extracellular matrix remodelling: the role of matrix metalloproteinases.
###end article-title 55
###begin article-title 56
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma.
###end article-title 56
###begin article-title 57
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma.
###end article-title 57
###begin article-title 58
The pathophysiology of tumor necrosis factors.
###end article-title 58
###begin article-title 59
Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.
###end article-title 59
###begin article-title 60
Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase.
###end article-title 60
###begin article-title 61
Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells.
###end article-title 61
###begin article-title 62
###xml 20 25 <span type="species:ncbi:9606">human</span>
Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.
###end article-title 62
###begin article-title 63
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.
###end article-title 63
###begin article-title 64
###xml 154 160 <span type="species:ncbi:9606">humans</span>
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.
###end article-title 64
###begin article-title 65
###xml 109 117 <span type="species:ncbi:9606">patients</span>
TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients.
###end article-title 65
###begin article-title 66
Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha.
###end article-title 66
###begin article-title 67
###xml 49 54 <span type="species:ncbi:9606">human</span>
Functional analysis of a new polymorphism in the human TNF alpha gene promoter.
###end article-title 67
###begin article-title 68
Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma.
###end article-title 68
###begin article-title 69
Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis.
###end article-title 69
###begin article-title 70
###xml 20 25 <span type="species:ncbi:9606">human</span>
Polymorphism of the human TNF-alpha promoter-random variation or functional diversity?
###end article-title 70
###begin article-title 71
Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome.
###end article-title 71
###begin article-title 72
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma.
###end article-title 72
###begin article-title 73
Association of tumour necrosis factor alpha -308 gene polymorphism with primary open-angle glaucoma in Chinese.
###end article-title 73
###begin article-title 74
TNF-alpha promoter polymorphisms and primary open-angle glaucoma.
###end article-title 74
###begin article-title 75
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma.
###end article-title 75

